Lifeline Biotechnologies Market Cap

Lifeline Biotechnologies has a market cap or net worth of $869.78 thousand as of May 23, 2025. Its market cap has decreased by -13.43% in one year.

Market Cap

869.78K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 869.78K, a decrease of -95.42%. That is a compound annual growth rate of -13.41%.

Market Cap History

Date	Market Cap	% Change
May 23, 2025	869.78K	100.00%
Dec 31, 2024	434.89K	-35.07%
Dec 28, 2023	669.78K	-33.33%
Dec 30, 2022	1.00M	50.00%
Dec 31, 2021	669.78K	-60.00%
Dec 31, 2020	1.67M	-37.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Veradigm	747.23M
Nika Pharmaceuticals	672.83M
Tian'an Technology Group	591.73M
Elite Pharmaceuticals	565.54M
Glass House Brands	452.21M
CytoDyn	423.89M
Northwest Biotherapeutics	399.66M

Market Cap Rankings